Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Experience -- Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry) A Post-Market Registry With the Barostim™ System

NCT04502316 is registered in ClinicalTrials.gov with CVRx, Inc. as lead sponsor.

NCT NCT04502316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04502316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Experience -- Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry) A Post-Market Registry With the Barostim™ System
Lead sponsor
CVRx, Inc.
Phase
Observational
Overall status
Terminated
Start date
June 26, 2020
Completion date
June 30, 2026
Enrollment
435 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure